News

Latest

A report by Premier, Inc., indicates dramatic spikes in demand for two antimalarial drugs that may influence positive COVID-19 outcomes.
The first Americans Sunday joined a nightly, worldwide movement that began in Europe to show support and gratitude to the nurses, physicians and other health care workers caring for patients during the COVID-19 pandemic.
As requested by AHA, the Centers for Medicare & Medicaid Services issued a corrected announcement regarding the Medicare Severity-Diagnosis Related Group Grouper to recognize the new ICD-10-CM diagnosis code, U07.1, for COVID-19.
The Centers for Medicare & Medicaid Services released a series of COVID-19 checklists and tools for states to use for their Medicaid and Children’s Health Insurance Programs.
The Centers for Medicare & Medicaid Services has released frequently asked questions regarding enrollment relief for Medicare providers in light of COVID-19.
The Food and Drug Administration issued the first emergency use authorization for a point-of-care COVID-19 diagnostic, which the maker plans to make available to qualified health care providers and CLIA-certified labs by March 30.
The Centers for Medicare & Medicaid Services granted a range of data reporting exceptions and extensions across its quality reporting and value-based payment programs for hospitals, post-acute care facilities and clinicians to relieve provider burden during the COVID-19 crisis.
The Department of Justice has established a website, hotline and email for reporting price gouging and fraud. The National Center for Disaster Fraud is coordinating the effort and will triage complaints to the appropriate federal and/or state authorities.
The AHA has asked the Department of Labor to accurately define “health care provider” as it promulgates regulations implementing key sections of the recently-enacted Families First Coronavirus Response Act and clarify how this policy will be operationalized, including how it interacts with state law.
Hospitals and health systems need additional federal funding to combat COVID-19, AHA President and CEO Rick Pollack said on CBS’ Face the Nation.